14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of OCUL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Ocular Therapeutix stock price on Wednesday which ended trading at $5.02
(Updated on May 01, 2024)

Sell candidate since Apr 18, 2024 Loss -14.33% PDF

The Ocular Therapeutix stock price gained 5.91% on the last trading day (Wednesday, 1st May 2024), rising from $4.74 to $5.02. During the last trading day the stock fluctuated 12.19% from a day low at $4.84 to a day high of $5.43. The price has fallen in 7 of the last 10 days and is down by -33.77% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $15.13 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.14% during the next 3 months and, with a 90% probability hold a price between $3.29 and $8.97 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

OCUL Signals & Forecast

There are mixed signals in the stock today. The Ocular Therapeutix stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $7.70. On a fall, the stock will find some support from the short-term average at $4.74. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, March 05, 2024, and so far it has fallen -54.07%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Ocular Therapeutix stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.75 and $4.65. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ocular Therapeutix finds support just below today's level at $4.75. If this is broken, then the next support from accumulated volume will be at $4.65 and $4.20.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.590 between high and low, or 12.19%. For the last week, the stock has had daily average volatility of 11.45%.

Ocular Therapeutix is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (OCUL) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Ocular Therapeutix to open at $5.10, and during the day (based on 14 day Average True Range), to move between $4.44 and $5.60, which gives a possible trading interval of +/-$0.581 (+/-11.58%) up or down from last closing price. If Ocular Therapeutix takes out the full calculated possible swing range there will be an estimated 23.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.08 (1.10%) than the support at $4.75 (5.48%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ocular Therapeutix stock A Buy?

Ocular Therapeutix holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -6.036 Strong Sell Candidate Downgraded

Predicted Opening Price for Ocular Therapeutix of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$5.10 ( 1.53%) $5.02

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for OCUL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.69 13.28 %
R2 5.46 8.79 %
R1 5.32 6.02 %
Current price: 5.02
Support S1 4.87 -2.96 %
S2 4.73 -5.74 %
S3 4.51 -10.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.86 16.73 %
R2 5.22 3.98 %
R1 5.08 1.10 %
Current price 5.02
Support S1 4.75 -5.48%
S2 4.65 -7.47%
S3 4.20 -16.33%

FAQ

What is the symbol for Ocular Therapeutix Stock and on which exchange is it traded?
The symbol for Ocular Therapeutix is OCUL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ocular Therapeutix Stock?
Ocular Therapeutix holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Ocular Therapeutix Stock?
Ocular Therapeutix Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ocular Therapeutix Stock.

What's the current price of Ocular Therapeutix Stock?
As of the end of day on the May 01, 2024, the price of an Ocular Therapeutix (OCUL) share was $5.02.

What is the 52-week high and low for Ocular Therapeutix Stock?
The 52-week high for Ocular Therapeutix Stock is $11.31 and the 52-week low is $2.00.

What is the market capitalization of Ocular Therapeutix Stock?
As of the May 01, 2024, the market capitalization of Ocular Therapeutix is 746.108M.

When is the next earnings date for Ocular Therapeutix?
The upcoming earnings date for Ocular Therapeutix is May 13, 2024.
Click to get the best stock tips daily for free!

About Ocular Therapeutix

Ocular Therapeutix Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammati... OCUL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT